Listing 1 - 7 of 7 |
Sort by
|
Choose an application
Age-Related Macular Degeneration (AMD) offers a consolidated view of a complex disorder by summarizing the latest evidence-based studies and translating their findings into practical, actionable knowledge. This concise resource covers the fundamentals of AMD diagnosis and treatment. It operates under a modern definition of AMD which acknowledges the range of presentations that ophthalmologists see in practice. Offering practical, clinical guidance in addition to capturing new therapeutic approaches in the pipeline, this book is an essential reference for ophthalmologists, optometrists, and researchers. . Takes a concise yet comprehensive approach to AMD, covering both basic science and clinical guidance. . Features clinical guidelines on the diagnosis and treatment of AMD, including classification, signs/symptoms, imaging, and differential diagnosis in the pre-optical coherence tomography (OCT) and modern OCT eras. . Presents up-to-date information on AMD therapies currently in the development pipeline and offers insights for the future of translational research. . Explains molecular genetics and pathogenic events of AMD from both basic and clinical perspectives, which may help readers seek promising new therapeutic targets . Contains more than 112 full-color illustrations with multimodal imaging techniques that clearly demonstrate AMD pathophysiology and clinical pathology.
Retinal degeneration --- Macular Degeneration --- Age factors. --- diagnosis. --- therapy.
Choose an application
Retinal degeneration --- Macular Degeneration --- Choroidal Neovascularization. --- Age factors. --- diagnosis. --- complications. --- therapy.
Choose an application
Retinitis pigmentosa. --- Retinal degeneration. --- Dystrophy, Retinal --- Macular degeneration --- Retina --- Retinal dystrophy --- Degeneration (Pathology) --- Pigmentation disorders --- Retinal degeneration --- Degeneration --- Diseases
Choose an application
Age-related Macular Degeneration Diagnosis and Treatment provides ?for the retina specialist, general eye care professional, vision scientist, and those training in these areas?an update on the current understanding of age-related macular degeneration (AMD), pathophysiology, the use of diagnostic tests, and the management of both non-neovascular and neovascular AMD. It also looks into the future with potential treatment options that are now under investigation in clinical trials, and finally, covers the medical economics and societal impact of this major public health issue. Special features of this book:
Ophthalmology --- oftalmologie --- Macular Degeneration --- Aged. --- Retinal degeneration --- Rétine --- diagnosis. --- therapy. --- Diagnosis --- Treatment. --- Dégénérescence --- Diagnostic --- Traitement --- EPUB-LIV-FT LIVMEDEC SPRINGER-B
Choose an application
Retinal degeneration. --- Age factors in disease. --- Age and disease --- Diseases --- Aging --- Dystrophy, Retinal --- Macular degeneration --- Retina --- Retinal dystrophy --- Degeneration (Pathology) --- Age factors --- Degeneration
Choose an application
Retinal degeneration --- Dystrophy, Retinal --- Macular degeneration --- Retina --- Retinal dystrophy --- Degeneration (Pathology) --- Patients --- Degeneration --- Diseases --- Danson, Barney. --- Canada. --- Canada --- Politics and government
Choose an application
"In Sight is a memoir about how a love of science and discovery drove Julia Levy, a celebrated scholar and biotech CEO, to work her way through gender bias in order to achieve academic and professional recognition. Her story traces the unconventional invention of a breakthrough drug treatment from its development from laboratory researchin the laboratory to its application as a medical treatment for vision loss. Told from a female perspective, In Sight is a unique and personal story covering Levy's early years as a refugee, her university training in the UK, and her appointment as professor at the University of British Columbia. Years spent as an academic led gave the author to unexpected exposure to the biotechnology industry and a chance meeting with colleagues that led to the formation of a lucrative biotechnology company, known today as QLT Inc. The bulk of the book covers the years spent building the company, and Levy's surprising transition from chief scientific officer to CEO. In Sight is an honest description of the trials of drug development, the tensions inherent in the commercialization of health innovations, and the truly remarkable hurdles faced by women in the scientific community."--
Microbiologists --- College teachers --- Levy, Julia G., --- Canada --- IPO. --- QLT. --- STEM. --- Visudyne. --- biography. --- biotechnology. --- careers. --- commercialisation of science. --- macular degeneration. --- memoir. --- photodynamic. --- therapy. --- women in business. --- women in science.
Listing 1 - 7 of 7 |
Sort by
|